Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Randomized, Controlled Study of Rituximab in Treatment of Primary IgA Nephropathy

NCT04525729 is registered in ClinicalTrials.gov with Nan Chen,MD as lead sponsor.

NCT NCT04525729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04525729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Randomized, Controlled Study of Rituximab in Treatment of Primary IgA Nephropathy
Lead sponsor
Nan Chen,MD
Phase
Phase 4
Overall status
Completed
Start date
July 1, 2020
Completion date
March 30, 2024
Enrollment
116 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

iga nephropathy